Concordia closes Amdipharm Mercury buy

Concordia Healthcare Corp. said Wednesday it closed its buy of Amdipharm Mercury Ltd. from Cinven and other sellers. The deal, announced in September, is valued at $3.5 billion. Once the transaction closes, Cinven own about 14.2 percent of Concordia. London-based Amdipharm Mercury is pharmaceutical company.

DealsNorth AmericaUSBriefs